Frazier Management LLC Alpine Immune Sciences, Inc. Transaction History

Frazier Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$6.41 - $13.89 $11.4 Million - $24.8 Million	-1,784,913 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$10.41 - $13.95 $136,048 - $182,312	13,069 Added 0.74%	1,784,913 $24.7 Million
Q3 2021 Nov 12, 2021	SELL	$8.19 - $11.31 $6.55 Million - $9.04 Million	-799,606 Reduced 31.1%	1,771,844 $18.9 Million
Q1 2019 May 15, 2019	BUY	$4.09 - $7.19 $1.52 Million - $2.68 Million	372,439 Added 16.94%	2,571,450 $17.6 Million
Q3 2017 Nov 13, 2017	BUY	$8.0 - $11.6 $17.6 Million - $25.5 Million	2,199,011	2,199,011 $25.5 Million

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.